Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
As of June 2025 Abbott Laboratories has a market cap of HK$1.808 Trillion. This makes Abbott Laboratories the world's 55th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | HK$1.808 T | 16.79% |
2024 | HK$1.548 T | 3.75% |
2023 | HK$1.492 T | -0.22% |
2022 | HK$1.495 T | -22.93% |
2021 | HK$1.940 T | 29% |
2020 | HK$1.504 T | 26.17% |
2019 | HK$1.192 T | 19.9% |
2018 | HK$994.39 B | 28.13% |
2017 | HK$776.10 B | 76.98% |
2016 | HK$438.53 B | -14.45% |
2015 | HK$512.61 B | -2.66% |
2014 | HK$526.60 B | 14.45% |
2013 | HK$460.13 B | -42.52% |
2012 | HK$800.47 B | 17.66% |
2011 | HK$680.34 B | 17.95% |
2010 | HK$576.78 B | -11.18% |
2009 | HK$649.35 B | 1.48% |
2008 | HK$639.89 B | -5.7% |
2007 | HK$678.55 B | 16.52% |
2006 | HK$582.37 B | 23.76% |
2005 | HK$470.56 B | -16.8% |
2004 | HK$565.54 B | -0.39% |
2003 | HK$567.74 B | 15.89% |
2002 | HK$489.87 B | -27.85% |
2001 | HK$678.94 B | 16.25% |
2000 | HK$584.03 B | 33.82% |
1999 | HK$436.42 B | -24.17% |
1998 | HK$575.54 B | 48.39% |
1997 | HK$387.84 B | 26.02% |
1996 | HK$307.76 B |
On Jun 18th, 2025 the market cap of Abbott Laboratories was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | HK$2.877 T | 59.15% | ๐บ๐ธ USA |
![]() Pfizer PFE | HK$1.071 T | -40.77% | ๐บ๐ธ USA |
![]() Thermo Fisher Scientific TMO | HK$1.163 T | -35.67% | ๐บ๐ธ USA |
![]() Hologic HOLX | HK$112.19 B | -93.80% | ๐บ๐ธ USA |
![]() Medtronic MDT | HK$867.10 B | -52.05% | ๐ฎ๐ช Ireland |
![]() Bristol-Myers Squibb BMY | HK$754.48 B | -58.28% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | HK$1.181 T | -34.67% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | HK$1.785 T | -1.28% | ๐ฌ๐ง UK |
![]() Novartis NVS | HK$1.820 T | 0.67% | ๐จ๐ญ Switzerland |
![]() GlaxoSmithKline GSK | HK$623.13 B | -65.54% | ๐ฌ๐ง UK |